Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

Etats-Unis|Canada
English|French

Dicerna Pharmaceutic

(NASDAQ: DRNA)
Ajouter à Portefeuille
-0,92 (-4,33%)
en date du fév 18, 2020


Date Formulaire Description HTML Word PDF Excel
Feb 10, 2020 8-K Current report filing
Feb 06, 2020 8-K Current report filing
Jan 13, 2020 8-K Current report filing
Dec 16, 2019 8-K Current report filing
Dec 06, 2019 SC 13D/A Amended Statement of Beneficial Ownership
Nov 21, 2019 SC 13D/A Amended Statement of Beneficial Ownership
Nov 18, 2019 8-K Current report filing
Nov 07, 2019 S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
Nov 07, 2019 10-Q Quarterly Report
Nov 07, 2019 8-K Current report filing
Oct 31, 2019 8-K Current report filing
Sep 23, 2019 8-K Current report filing
Sep 19, 2019 8-K Current report filing
Aug 08, 2019 S-8 Securities Registration: Employee Benefit Plan
Aug 08, 2019 10-Q Quarterly Report
Aug 08, 2019 8-K Current report filing
Jun 24, 2019 8-K Current report filing
May 31, 2019 SC 13D/A Amended Statement of Beneficial Ownership
May 10, 2019 10-Q Quarterly Report
May 09, 2019 8-K Current report filing
Apr 29, 2019 DEFA14A Additional Proxy Soliciting Materials (definitive)
Apr 29, 2019 DEF 14A Proxy Statement (definitive)
Mar 21, 2019 CT ORDER Confidential Treatment Order        
Mar 13, 2019 10-K Annual Report
Mar 11, 2019 8-K Current report filing